American Psychiatric Association Annual Meeting

Dr Steven Adelsheim Explains How Community Partnerships Can Support Young Patients With Mental Illness

September 09, 2019

It’s crucial to have support from the numerous community settings that young people interact with so that they can feel understood and better manage their mental illness, according to Steven Adelsheim, MD, clinical professor of psychiatry and behavioral sciences, Stanford University School of Medicine.

Dr Steven Adelsheim Outlines Components of Screening for Psychosis in Young People

August 30, 2019

Early intervention in potential cases of psychosis among young people hinges on multiple settings being aware of the early signs of the illness and able to link people to treatment, said Steven Adelsheim, MD, clinical professor of psychiatry and behavioral sciences, Stanford University School of Medicine.

Dr Jacob Ballon Discusses the Opportunity to Use Big Data to Identify Types of Psychotic Illnesses

August 26, 2019

Jacob Ballon, MD, MPH, clinical associate professor, psychiatry and behavioral sciences, Stanford University, explained how large databases can help researchers understand the variety of psychotic illnesses, potentially leading to more personalized treatments.

Dr Steven Adelsheim Notes Key Issues When Assessing Potential Early Psychosis in Young Patients

August 20, 2019

When assessing young people for potential early psychosis, psychiatrists should keep in mind that reassurance is particularly important for this patient group, explained Steven Adelsheim, MD, clinical professor of psychiatry and behavioral sciences, Stanford University School of Medicine.

Dr Jacob Ballon: Looking Beyond Schizophrenia Symptoms to Treat the Whole Person

August 15, 2019

Providers should treat patients with schizophrenia by thinking about them as people and understanding the full context of their lives, according to Jacob Ballon, MD, MPH, clinical associate professor, psychiatry and behavioral sciences, Stanford University.

Dr Steven Adelsheim: Special Considerations When Treating Young People With Psychosis

August 09, 2019

Providers who treat young people with psychosis must navigate a host of issues unique to this population, including confidentiality and consent rules, the role of the family, and support from schools, according to Steven Adelsheim, MD, clinical professor of psychiatry and behavioral sciences, Stanford University School of Medicine.

Dr Jacob Ballon on the Importance of Early Intervention, Comprehensive Treatment in Psychosis

August 04, 2019

Early intervention is important in many illnesses, including psychosis, so treatment can begin as early as possible for best outcomes, explained Jacob Ballon, MD, MPH, clinical associate professor, psychiatry and behavioral sciences, Stanford University. He also discussed a resource for learning more about early intervention.

Adam Simmons: ENLIGHTEN-2 Data Demonstrate Efficacy, Reduced Weight Gain With ALKS 3831

August 02, 2019

Data presented at the 175th Annual Meeting of the American Psychiatric Association (APA) support the potential of the investigational drug ALKS 3831 to provide the antipsychotic efficacy of olanzapine without the associated weight gain, said Adam Simmons, director of clinical program management, Alkermes. He also discussed the timing of when the data might be filed with the FDA.

Adam Simmons Explains the Short- and Long-term Value of ALKS 3831 to Payers and Patients

July 26, 2019

Adam Simmons, director of clinical program management, Alkermes, explains that an investigational antipsychotic drug, ALKS 3831, provides the efficacy of olanzapine without the associated weight gain can provide benefits in the short and long term to payers and patients. Simmons spoke about data presented at the 175th Annual Meeting of the American Psychiatric Association in San Francisco, California.

Dr David Kingdon Discusses Efforts to Increase Understanding of Psychosis

July 25, 2019

Increasing awareness of psychosis can help communities engage with patients on a human level and work together to improve, according to David Kingdon, MD, professor of mental health care delivery, University of Southampton.